EDRH
TEVA icon

Edmond de Rothschild Holding’s Teva Pharmaceuticals TEVA Stock Holding History

Edmond de Rothschild Holding’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-7,000
Closed -$1K – 851
2017
Q1 		$1K Hold
7,000
– – ﹤0.01% 812
2016
Q4 		$2K Hold
7,000
– – ﹤0.01% 806
2016
Q3 		$7K Hold
7,000
– – ﹤0.01% 797
2016
Q2 		$20K Buy
+7,000
New +$373K ﹤0.01% 730

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Edmond de Rothschild Holding's TEVA Position: Q1 2026 in Review

Edmond de Rothschild Holding held its Teva Pharmaceuticals (TEVA) position steady in Q1 2026 at 8,845 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #363.

Edmond de Rothschild Holding first reported a position in TEVA in Q2 2015 and has held it in 44 quarters since. The position peaked at $1.14M in Q2 2015. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Edmond de Rothschild Holding held 8,845 shares of Teva Pharmaceuticals worth $266K as of Q1 2026.
  • Edmond de Rothschild Holding left its Teva Pharmaceuticals share count unchanged in Q1 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Edmond de Rothschild Holding's portfolio in Q1 2026, its #363 holding.
  • Edmond de Rothschild Holding first reported a position in Teva Pharmaceuticals in Q2 2015 and has held it in 44 quarters since.
  • Edmond de Rothschild Holding's Teva Pharmaceuticals position peaked at $1.14M in Q2 2015.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Edmond de Rothschild Holding's 13F filing for Q1 2026, filed 13 May 2026.